SABSW Latest Press Releases

-- September 1, 2026 --

SAB BIO to Participate in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- August 6, 2026 --

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights Globe Newswire 7:30 AM

-- July 30, 2026 --

SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET Globe Newswire 8:30 AM

-- July 7, 2026 --

Breakthrough T1D Awards Grant to Support PRISE-hATG Study of SAB-142 in Stage 3 Type 1 Diabetes Globe Newswire 8:00 AM

-- May 29, 2026 --

SAB BIO to Present Data on SAB-142 at The American Diabetes Association's 2026 Scientific Sessions and FOCIS 2026 Annual Meeting Globe Newswire 8:00 AM

-- May 12, 2026 --

SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights Globe Newswire 7:30 AM

-- May 5, 2026 --

SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET Globe Newswire 8:30 AM

-- April 22, 2026 --

SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software